3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akita, H | 1 |
| Honda, Y | 1 |
| Ogata, M | 1 |
| Noda, K | 1 |
| Saji, M | 1 |
| Marin, C | 1 |
| Jimenez, A | 1 |
| Bonastre, M | 1 |
| Chase, TN | 1 |
| Tolosa, E | 1 |
2 other studies available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Activation of the NMDA receptor involved in the alleviating after-effect of repeated stimulation of the subthalamic nucleus on motor deficits in hemiparkinsonian rats.
Topics: Animals; Deep Brain Stimulation; Dizocilpine Maleate; Dyskinesias; Excitatory Amino Acid Antagonists | 2010 |
Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Dextromethorphan; Excitatory Amino Acid Antagonists; Levodopa; Male; | 2000 |